Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The use of Low Flow Nasal Prongs Therapy in weaning nasal Continuous Positive Airway Pressure (nCPAP) in neonates. Anecdotal or Evidence Based?
ISRCTN ISRCTN02529072
ClinicalTrials.gov identifier
Public title The use of Low Flow Nasal Prongs Therapy in weaning nasal Continuous Positive Airway Pressure (nCPAP) in neonates. Anecdotal or Evidence Based?
Scientific title The use of Low Flow Nasal Prongs Therapy in weaning nasal Continuous Positive Airway Pressure (nCPAP) in neonates. A Multicentre Randomised Controlled Trial
Acronym NOFLO Trial
Serial number at source N/A
Study hypothesis The aim of the study is to determine if improved weaning of neonates less than 1500g from nCPAP can be observed using low flow nasal prongs therapy versus self ventilation after minimal nCPAP settings have been reached. We hypothesise that low flow nasal prong therapy will decrease failure rate of weaning.
Lay summary Not provided at time of registration
Ethics approval 1. Research Ethics Committee, Coombe Women and Infants University Hospital, Dublin, Ireland approved on the 23rd of September 2009 (ref: 18 - 2009)
2. Ethics Commitee of Institute for Clinical and Experimental Medicine and Faculty of Thomayer Hospital, Prague, Czech Reupublic approved on the 13th of January 2010 (ref: 2500 - 09 [A 10-01-03])
Study design Multicentre randomised controlled parallel group trial
Countries of recruitment Czech Republic, Ireland
Disease/condition/study domain Respiratory Distress Syndrome in very low birth weight infants.
Participants - inclusion criteria 1. Neonates with a birth weight of 1500g or less.
2. Ventilation support for a minimum of 48 hours (including nCPAP), with successful weaning to an oxygen concentration of room air.
3. Maintenance on a minimum end expiratory pressures of 3-5 cm of H2O on nCPAP. The neonate must be comfortably maintained on these nCPAP settings without significant apnoea or respiratory distress for at least 24 hours.
Participants - exclusion criteria Neonates with associated congenital/respiratory/cardiac abnormality at the time of weaning of CPAP.
Anticipated start date 01/02/2010
Anticipated end date 31/12/2010
Status of trial Completed
Patient information material Not available in web format, please contact the investigating unit to request a patient information sheet
Target number of participants 78
Interventions Intervention Group: Use of Low Flow Nasal Prongs therapy for weaning from nCPAP.
Control Group: Self Ventilation on weaning from nCPAP.

Study duration and monitoring will be for 5 consecutive days following weaning from nCPAP
Primary outcome measure(s) Failure rate of weaning from nCPAP. Failure of weaning defined by:
1. More than one self correcting apnoeic episode per hour (defined as a bradycardia < 100/min with concurrent saturations of less than 80% lasting ≥ 20 seconds) or one apnoeic episode requiring either stimulation or bag and mask ventilation.
2. Need for Oxygen to maintain saturations >85%.
3. A score of 6-10 on the Silverman-Anderson Respiratory Scale. This is an evaluation of respiratory status and work of breathing. A score of 6-10 will indicate moderate to severe respiratory distress.
If these criteria are reached they will be placed back on nCPAP at the settings they had been maintained on at the time of weaning.
Secondary outcome measure(s) 1. Length of time to failure
2. Changes in status, assessed hourly
2.1. heart rate
2.2. respiratory rate
2.3. saturations
2.4. frequency of apnoeas
3. Change in Silverman - Anderson Respiratory Score, assessed every 4 hours
Sources of funding Coombe Women and Infants University Hospital (Ireland)
Trial website
Publications
Contact name Dr  Jan  Miletin
  Address Neonatal Unit,
Coombe Women and Infants University Hospital,
Cork Street,
Dolphin's Barn,
  City/town Dublin
  Zip/Postcode D8
  Country Ireland
  Tel +353 (0)1 4085654
  Email jmiletin@coombe.ie
Sponsor Coombe Women and Infants University Hospital (Ireland)
  Address Cork Street,
Dolphin's Barn
  City/town Dublin
  Zip/Postcode D8
  Country Ireland
  Tel +353 (0)1 4085276
  Fax +353 (0)1 4536033
  Email jmiletin@coombe.ie
Date applied 02/02/2010
Last edited 11/10/2011
Date ISRCTN assigned 24/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central